Acidosis may augment cerebral ischemic in jury by promoting lipid peroxidation. We tested the hy pothesis that when acidosis is augmented by hyperglyce mia, pretreatment with the 21-aminosteroid tirilazad mes ylate (U74006F), a potent inhibitor of lipid peroxidation in vitro, improves early cerebral metabolic recovery. In a randomized, blinded study, anesthetized dogs received either tirilazad mesylate (1 mg/kg plus 0.2 mg/kg/h; n = 8) or vehicle (n = 8). Hyperglycemia (400-500 mg/dl) was produced prior to 30 min of global incomplete cerebral ischemia. Intracellular pH and high energy phosphates were measured by phosphorus magnetic resonance spec troscopy. During ischemia, microsphere-determined CBF decreased to 8 ± 4 ml min -I 100 g-I and intracellular pH decreased to 5.6 ± 0.2 in both groups. During the first 20 min of reperfusion, ATP partially recovered in the vehicle group to 57 ± 21% of baseline, but then declined progres-Acidosis is one of several mechanisms thought to contribute to ischemic injury (Siesj6 et aI., 1993). The precise molecular mechanism whereby acidosis augments injury has not been elucidated. By alter ing protein charge, pH is expected to alter protein function. However, severe acidosis induced by ex treme hypercapnia does not produce irreversible in jury (Xu et aI., 1991), suggesting that pH-induced changes in protein charge per se are insufficient to cause injury. Even in the presence of ischemia and ATP depletion, augmenting acidosis by hypercap nia does not produce the same impairment of met-
sively in association with elevated intracranial pressure. By 30 min, ATP recovery was greater in the tirilazad group (77 ± 35 vs. 36 ± 19%), although postischemic hyperemia was similar. By 45 min, the tirilazad group had a higher intracellular pH (6.5 ± 0.5 vs. 5.9 ± 0.6) and a lower intracranial pressure (18 ± 6 vs. 52 ± 24 mm Hg). By 180 min, blood flow and ATP were undetectable in seven of eight vehicle-treated dogs, whereas ATP was >67% and pH was >6.7 in six of eight tirilazad-treated dogs. Thus, tirilazad acts during early reperfusion to pre vent secondary metabolic decay associated with severe acidotic ischemia. If tirilazad acts by inhibiting lipid per oxidation, then these data are consistent with extreme acidosis limiting recovery by a mechanism involving lipid peroxidation. Key Words: Antioxidants-Hypergly cemia-Magnetic resonance spectroscopy-pH Tirilazad mesylate. abolic recovery as when acidosis is augmented by hyperglycemia (Hum et aI., 1991b) . Based on dif ferences in lipid peroxidation induced in vitro be tween hypercapnic acidosis and lactic acidosis, Rehncrona et a1. (1989) proposed that lactic acid, but not carbonic acid, attacks carbonate binding sites for iron on transferrin, thereby mobilizing iron and catalyzing lipid peroxidation. If this hypothesis is valid, then one would expect that administration of antioxidants that inhibit lipid peroxidation would improve recovery in situations in which lactic aci dosis is a predominant mechanism of injury.
In the present study, we used the antioxidant ti rilazad mesylate (U74006F). This 21-aminosteroid is a potent inhibitor of lipid peroxidation in vitro including brain homogenate (Braughler et aI., 1987; Braughler and Pregenzer, 1989; Hall et aI., 1991b) and attenuates the decrease in endogenous antiox idants associated with prolonged ischemia (Hall et aI., 1991a; Sato and Hall, 1992) . This agent has been found to be protective in several models of severe global ischemia (Hall and Yonkers, 1988; Hall et aI., 1988; Natale et aI., 1988; Perkins et aI., 1991) , al though protection of selectively vulnerable neurons in models thought to evoke primarily excitotoxic mechanisms has been less consistent (Beck and Bielenberg, 1990; Lesiuk et aI., 1991; Buchan et aI., 1992) . Efficacy of tirilazad has not been well eval uated in a model of hyperglycemic ischemia where severe acidosis becomes the primary mechanism limiting metabolic recovery. Therefore, we evalu ated the effect of tirilazad pretreatment in a model of severe hyperglycemic incomplete cerebral isch emia in which tissue lactate levels are augmented during ischemia and reperfusion and the severity of acidosis results in only transient recovery of cere bral energy metabolism (Hum et aI., 1991a) . We tested the hypothesis that pretreatment with tiri lazad mesylate improves recovery of high energy phosphates and intracellular pH determined by phos phorus magnetic resonance spectroscopy (MRS).
METHODS
Male dogs (-lO kg) were anesthetized intravenously with fentanyl (50 f.Lg/kg) and pentobarbital (10 mg/kg). Additional pentobarbital was infused throughout the sur gery and experiment at a rate of 3 mg/kg/h. Lungs were mechanically ventilated with 25-30% O2, and end-tidal CO2 concentration was controlled. Femoral veins were catheterized for drug administration and a femoral artery was catheterized for blood pressure monitoring. The left ventricle was catheterized via a femoral artery for injec tion of radiolabeled microspheres, and an axillary artery was catheterized for obtaining the microsphere reference sample. Muscles were paralyzed with intravenous pancu ronium bromide (0.3 mg/kg) , and temporalis muscles were fully retracted. Through burr holes in the skull, catheters were inserted into the sagittal sinus and left lateral ventricle, and a thermistor was inserted into the epidural space. An electrode was secured in a burr hole in the skUll over the right somatosensory cortex. Amplitude of the primary cortical wave complex of the somatosen sory evoked potential with left forelimb stimulation was measured (Nishijima et al., 1989; Hum et al., 1991a) .
CBF was measured with micro spheres (15 ± 0.5-f.Lm diameter; DuPont-NEN, Boston, MA, U.S.A.) labeled with one of six 'V-emitters ('5  3 Gd,  11 4 m In,  113 Sn,  103 Ru, 95Nb, 4 6SC) as previously described (Nishijima et aI., 1989; Hum et aI., 1991a) . Arterial and sagittal sinus blood gases and pH were determined with a Radiometer ABL3 electrode system (Copenhagen, Denmark), O2 content was determined with a CO oximeter (Instrumentation Laboratories, Lexington, MA, U.S.A.), and glucose con centration was measured with a Yellow Springs glucose analyzer (model 23A; Yellow Springs, OH, U.S.A.). CMR02 was calculated from the arterial-sagittal sinus O2 content difference and blood flow to the entire cerebrum. Extracranial contamination of sagittal sinus blood from diploic veins was assumed to be small and of similar mag nitude in each treatment group. Phosphorus MRS was performed with a 5-cm surface coil tuned to 32.5 MHz in a 1.89-T superconducting mag net with a 25-cm bore diameter (Oxford Instruments, Ox ford, England) as previously described (Nishijima et aI., 1989; Hum et aI., 1991a; Helfaer et al., 1992; Maruki et aI., 1993a) . Areas under the peaks corresponding to phos phocreatine and the j3-phosphorus of ATP were measured by planimetry and normalized by the corresponding areas of the baseline spectra. Intracellular pH was calculated from the chemical shift of Pi (Petroff et al., 1985) . Intra cellular bicarbonate ion was estimated from the Hender son-Hasselbalch equation using the pH derived from the magnetic resonance spectra and sagittal sinus partial pressure of CO2 (Pc02) as an estimate of tissue Pc02 (Nishijima et aI., 1989; Hum et aI., 1991a,b) . Dogs were maintained normothermic by placing them on a warm water-perfused blanket and wrapping the body in a plastic bag. In addition, a blanket of fiberglass insu lation was placed above the skUll to reduce radiant heat loss. After obtaining baseline measurements, a solution of 10% dextrose was infused intravenously at a rate suffi cient to maintain arterial glucose concentration at -400-500 mg/dl just prior to ischemia. The infusion continued during ischemia and was stopped at reperfusion. To pro duce global incomplete cerebral ischemia, artificial cere brospinal fluid was infused from a 38°C pressurized res ervoir through a 38°C water jacket and into the lateral ventricular catheter. Intracranial pressure (ICP) , mea sured off a separate side port of the catheter, was kept 10-15 mm Hg below MABP for 30 min while arterial pres sure spontaneously changed. This procedure maintains CBF relatively constant throughout ischemia (Hum et aI., 1991a,b) . To start reperfusion, the pressurized reservoir was disconnected and ICP rapidly decreased. At 3 h of reperfusion, the anesthetized dogs were killed by intra venous potassium chloride injection. The timing of all measurements was the same as previously reported (Maruki et aI., 1993b) .
Dogs were randomized into two groups of eight dogs each. One group received tirilazad mesylate at an initial dose of 1 mg/kg (1.5 mg/ml) intravenously over a lO-min period starting 20 min before ischemia. The drug was con tinuously infused at a rate of 0.2 mg/kg/h throughout reperfusion. A second group received the vehicle consist ing of 0.02 M citric acid monohydrate/0.0032 M sodium citrate dihydrate/ O.077 M NaCI. The pH of the solution was 3.0. Dogs with CBF values of <lor >14 ml min -I 100 g-I during ischemia were excluded. Based on expe rience, dogs with CBF of> 14 ml min -I 100 g-I did not achieve high energy phosphate depletion or tissue acido sis sufficient to cause global metabolic deterioration dur ing reperfusion. Two dogs in the vehicle group and three dogs in the tirilazad group were excluded and replaced. Investigators were blinded to treatment and remained blinded until all experiments were analyzed and excluded dogs were replaced.
Statistical analysis included split-plot two-way analysis of variance (ANOV A) in which drug treatment was a be tween-subject factor and repeated measures over time was a within-subject factor. If the F value for overall group effect or for group x time interaction was signifi cant, mean values between groups at individual time points were compared by orthogonal contrasts. The level of significance was p < 0.05 in all tests. Data are reported as means ± SD. Because the SD of CBF increased during postischemic hyperemia, a logarithmic transformation was performed on all CBF values. 
RESULTS
Before the start of ischemia, arterial glucose con centration was increased to 406 ± 101 mg/dl in the vehicle group and to 438 ± 56 mg/dl in the tirilazad group. Glucose levels increased further during isch emia to �600 mg/dl and then declined during reper fusion (Table O . There were no differences between groups in arterial glucose concentration, arterial pH, arterial blood gases, and O2 content ( Table O . Mean values of epidural temperature were 37-38°C and were not different between groups. MABP was maintained near baseline levels through 90 min of repenusion, but decreased at 180 min ( Table O. High levels of ICP were produced to reduce ce rebral penusion pressure to mean values of 12-13 mm Hg throughout 30 min of ischemia ( Fig. O . Dur ing early repenusion, ICP decreased to near base line levels and penusion pressure was rapidly re stored. However, two-way ANOV A on ICP values during repenusion indicated an overall effect of drug treatment (p < 0.02), and orthogonal contrasts indicated significantly higher ICP in the vehicle group starting at 30 min of repenusion. Dunnett's test indicated a significant increase in ICP above preischemic baseline levels after 30 min of repenu sion in the vehicle group, whereas those in the tirilazad group were not different from baseline. Ce rebral penusion pressure decreased below baseline levels by 45 min of reperfusion in the vehicle group and by 120 min in the tirilazad group.
During ischemia, CBF decreased to 8 ± 4 ml min -1 100 g-1 in both groups. Within each dog, CBF was reduced similarly in primary arterial sup ply territories, watershed territories, subcortical white matter, caudate, thalamus, cerebellum, and brainstem. No region had zero blood flow. The magnitude and duration of postischemic hyperemia were similar in both groups (Fig. 2 ). However, ANOVA indicated a significant group x time inter action (p < 0.002 on log CBF), and CBF in the vehicle group was lower than that in the tirilazad group at 90 and 180 min of reperfusion. CBF was less than baseline values at 90 and 180 min in the vehicle group and at 180 min in the tirilazad group.
During ischemia, CMR02, ATP, and phosphocre atine were reduced equivalently between groups (Figs. 2 and 3) . In the vehicle group, these three measures of energy metabolism partially recovered during the first 30 min of reperfusion, but subse quently declined concurrently with the rise in ICP and fall in CBF. In the tirilazad group, six of eight dogs exhibited sustained levels of ATP and phos phocreatine equivalent to at least two-thirds of baseline levels. Two-way ANOV A indicated a sig nificant group x time interaction for CMR02 (p < 0.002), ATP (p < 0.0001), and phosphocreatine (p < 0.04). Orthogonal contrasts indicated higher recov ery levels in the tirilazad group by 90 min for CMR02 and by 30 min for ATP and phosphocreat ine.
Intracellular pH decreased during ischemia to 5.62 ± 0.21 in the vehicle group and to 5.60 ± 0.18 in the tirilazad group, accompanied by correspond ing decreases in estimated intracellular bicarbonate levels to 0.8 ± 0.77 and 0.7 ± 0.35 mM. In the vehicle group, cerebral pH remained extremely low at �6.0 throughout reperfusion, and bicarbonate levels recovered only slightly (Fig. 4) . In the tiri lazad group, six of eight dogs exhibited sustained recovery of intracellular pH to >6.7. Group x time interactions on two-way ANOV A were significant for pH (p < 0.0001) and bicarbonate (p < 0.002), and mean values were greater in the tirilazad group as early as 45 min for pH and 30 min for bicarbon ate.
To ensure that the ischemic insult was well matched between groups and to evaluate if the se verity of the ischemic insult within each group in fluenced metabolic recovery, individual data of re-covery of ATP were plotted against CBF and intra cellular pH during ischemia and against arterial glucose levels before ischemia (Fig. 5 ). Within the vehicle group, only one of eight dogs had significant ATP at 180 min, and that dog had the highest CBF, the second highest pH, and an intermediate glucose level. Within the tirilazad group, two of eight dogs had undetectable ATP at 180 min. These two dogs had the lowest CBF during ischemia in that group, and one of these dogs had the lowest pH during ischemia and the highest preischemic blood glucose concentration within that group. Thus, the one dog in the vehicle group with good metabolic recovery had the least severe ischemic insult in that group, whereas the two dogs in the tirilazad group with poor metabolic recovery had the most severe isch emic insult in that group.
Somatosensory evoked potential remained iso electric throughout reperfusion in all eight dogs in obtained during hyperglycemic ischemia in the individual dogs treated with vehicle or tirilazad. The range of CBF at tained during ischemia was balanced among groups. How ever, only one of eight dogs in the vehicle group had detect able ATP recovery and that dog had the highest CBF in the group. Of the eight dogs in the tirilazad group, four had com plete ATP recovery, two had incomplete ATP recovery, and two had undetectable ATP at 180 min. The two dogs with no ATP recovery had the lowest CBF during ischemia in the group. B: ATP recovery at 180 min versus the intracellular pH (pH;) attained during ischemia. The one dog in the vehicle group with measurable ATP at 180 min had the second high est pH;. One of the two dogs in the tirilazad group with no ATP recovery had the lowest pH;. C: ATP recovery at 180 min versus arterial glucose concentration before ischemia. The one dog in the vehicle group with ATP recovery had an in termediate glucose level, whereas the dog in the tirilazad group with the lowest pH; and no ATP recovery had the high est glucose level in that group.
the vehicle group and in the two dogs in the tirilazad group with poor A TP recovery. Of the six dogs in the tirilazad group with sustained ATP recovery, four dogs had measurable evoked potentials at 180 min (amplitude of 51 ± 37% of baseline), one dog had an isoelectric potential, and in one dog evoked potentials could not be obtained because of techni cal difficulties. In the tirilazad group as a whole (including those with no ATP recovery), recovery of evoked potential amplitude was 29 ± 38% (n = 7).
DISCUSSION
Data from the vehicle group demonstrated that dogs subjected to 30 min of severe hyperglycemic incomplete cerebral ischemia, during which intra cellular pH falls to �5. 6, show only partial recovery of high energy phosphates during the first 30 min of reperfusion, followed by a secondary decay in high energy phosphates and progressive elevations of ICP and reductions in CBF. Transient metabolic recovery was inadequate to restore intracellular pH, and severe acidosis persisted throughout reper fusion. These results in vehicle-treated dogs con firm previous work in this experimental model (Hum et aI., 1991a) . Metabolic deterioration during reperfusion has also been reported in other models of global hyperglycemic ischemia (Welsh et aI., 1980; Rehncrona et aI., 1981; Kozuka et aI., 1989; Wagner et aI., 1989; Widmer et aI., 1992) . The ma jor finding of the present study is that administra tion of the 21-aminosteroid tirilazad improved re covery of high energy phosphates, tissue acidosis, and ICP as early as 30-45 min of reperfusion, pre vented the delayed reduction in CBF and CMR0 2 , and partially restored synaptic transmission and the ability to conduct action potentials in the somato sensory pathway. These results suggest that tiri lazad acts to counter an acidosis-dependent mech anism that limits metabolic viability during early reperfusion.
One potential mechanism by which acidosis may limit recovery involves oxygen radicals (Siesjo et aI., 1985 (Siesjo et aI., , 1993 . Rehncrona et al. (1989) postulated that lactic acid attack of carbonate bridges on trans ferrin leads to mobilization of iron and propagation of lipid peroxidation. Hum et al. (1991b) observed that increasing Pco2 during normoglycemic isch emia, which reduced intracellular pH to the same level as that presently attained during hyperglyce mia, while theoretically acting to stabilize carbon ate bridges, resulted in 100% metabolic and pH re covery. These results emphasized the role of bicar bonate depletion in the acidosis limitation of metabolic recovery and are consistent with the hy pothesis of Rehncrona et al. (1989) . The precise mechanism of action of tirilazad in vivo is not known conclusively. Because the drug inhibits lipid peroxidation in vitro (Braughler et al., 1987; Braughler and Pregenzer, 1989; Hall et aI., 1991b) and attenuates depletion of endogenous antioxi dants such as vitamin E and vitamin C after isch emia in vivo (Hall et aI., 1991a; Sato and Hall, 1992) , tirilazad may act by inhibiting lipid peroxida tion in vivo. If so, our results with tirilazad would be consistent with the hypothesis that acidosis aug ments ischemic injury by an oxygen radical mech anism. However, because we did not directly mea sure lipid peroxidation in this model, this conclu sion remains speculative. As discussed by Watson (1993) , tirilazad may act to stabilize membranes and thereby inhibit the spread of oxygen radical damage to adjacent compartments, rather than act by inhib iting the initiation of lipid peroxidation.
Several 31 p-MRS-based studies using compres sion ischemia in dogs from our laboratory support the concept that extremely low bicarbonate levels are required to affect early metabolic recovery by a tirilazad-sensitive mechanism. Following 12 min of complete cerebral ischemia in which acidosis is se vere but intracellular bicarbonate is estimated to remain >2 mM because of lack of CO2 clearance, recovery of high energy phosphates and pH is near normal (Nishijima et aI., 1989) and not accelerated by tirilazad treatment (Helfaer et aI., 1992) . During 30 min of normoglycemic incomplete ischemia when CO2 is partially cleared and intracellular bi carbonate is estimated to decrease to 1.7 mM, re covery of high energy phosphates and pH is near normal (Hum et aI., 1991a) , but tirilazad acceler ates pH recovery (Maruki et aI., 1993b) . In the present study of 30 min of hyperglycemic incom plete ischemia when intracellular bicarbonate was estimated to decrease to 0. 8 mM, recovery of high energy phosphates and pH was grossly impaired and tirilazad markedly improved metabolic recov ery in this case. Therefore, the efficacy of tirilazad in improving early metabolic recovery appears to depend on attaining critically low bicarbonate lev els, and hence on the duration and severity of isch emia as well as on the glucose level. In this regard, it is remarkable that the drug appears more effica cious in affecting metabolic recovery when the se verity of acidosis is increased by hyperglycemia compared with studies of normoglycemic ischemia (Harald seth et aI., 1991; Maruki et aI., 1993b) .
During ischemia, there were no significant differ ences in the measured variables between groups. The levels of CBF, tissue pH, and glucose were similar between groups (Fig. 5) . Thus, tirilazad pre treatment did not act by decreasing the severity of the ischemic insult. Differences between groups in ATP, phosphocreatine, estimated intracellular bi carbonate, and ICP became evident by 30 min of reperfusion. Thus, if tirilazad is acting by inhibiting lipid peroxidation, then lipid peroxidation occurs in early reperfusion and is of sufficient magnitUde un der conditions of extreme acidosis to limit meta bolic recovery. Tirilazad may act (a) at the mito chondrial level to improve metabolism, (b) at the cell membrane to restore ionic conductance, or (c) at the vascular level to improve reperfusion. As dis cussed herein, our data do not distinguish these possibilities.
In regard to the first possibility, oxygen radicals and lactic acidosis inhibit mitochondrial function in vitro (Hillered and Ernster, 1983; Hillered et aI., 1984) , and mitochondrial phospholipids are de graded after prolonged ischemia (Nakahara et aI., 1991) . Improved recovery of high energy phos phates in our study is consistent with improved ox idative phosphorylation.
In regard to the second possibility, concurrent improvements in intracellular bicarbonate and ICP, presumably reflecting less edema are also consis tent with improved restoration of ionic gradients.
Ability to generate somatosensory evoked poten tials, albeit at reduced amplitude, also infers resto ration of ionic gradients. Restored ionic gradients will decrease ATP demand and could account for accelerated A TP recovery. Thus, our data are also consistent with tirilazad acting at the cell membrane level to ameliorate ionic leakage.
In regard to the third possibility, the lack of a difference in CBF during the first 30 min of reper fusion when metabolic differences become signifi cant argues against a vascular mechanism of action of tirilazad. However, our microsphere measure ments of bulk CBF do not reflect capillary hetero geneity. Reperfusion after normoglycemic ischemia can lead to occasional patches of tissue with poor capillary blood flow (Theilen et aI., 1993) , and these patches can be more widespread after hyperglyce mic ischemia (Ginsberg et aI., 1980) . Endothelial swelling is evident at 5 min of reperfusion after hy perglycemic ischemia in the rat (Paljarvi et aI., 1983) . Whether capillary reflow heterogeneity is significant during the first 30 min of reperfusion in our model is not known. Certainly the large in crease in ICP and decrease in CBF to near-zero levels in many of the vehicle-treated dose at 90 and 180 min of reperfusion are the results of massive swelling. The decrease in MABP at 180 min, possi bly reflecting loss of brains tern function, also con tributed to the delayed decrease in CBF. However, at 30 min when group differences in A TP and phos phocreatine were evident, MABP in the vehicle group was higher (not lower) than in the tirilazad group (Table 1 ). Nevertheless, it is possible that differences in ICP at 30 min (39 mm Hg with vehicle vs. 14 mm Hg with tirilazad) reflect differences in cell swelling sufficient to cause heterogeneous CBF.
Hence, hyperglycemic ischemia appears to cause a vicious cycle of inadequate energy metabolism, ionic leaks, cell swelling, and poor reflow. Because it is difficult to ascertain which of these processes is the primary causative process and which is the sec ondary result, it is unclear at which point tirilazad acts to break the cycle. Furthermore, severe acido sis persisted throughout reperfusion in the vehicle group. Acidosis during reperfusion can cause addi tional electrophysiological deficits (Maruki et aI., 1993a) . Once iron is mobilized, acidosis promotes lipid peroxidation (Siesj6 et al., 1985) . Thus, persis tent acidosis during reperfusion may augment the vicious cycle and accelerate metabolic deteriora tion.
After 15 min of hyperglycemic ischemia in the rat, Lundgren et aL (1991) failed to detect oxygen radical damage. In this model, intracellular pH was estimated to decrease to 5.95 (Smith et aI., 1986) , which is higher than the 5.6 value presently ob tained with 30 min of ischemia. One explanation is that the 15-min duration of ischemia was not suffi ciently long to attain a critically low level of bicar bonate for destabilizing the transferrin carbonate bridges. In the present study and previous studies (Hum et aI., 1991b) , metabolic recovery is grossly impaired when intracellular bicarbonate ion con centration falls below 1 mM. Thus, a long duration of hyperglycemic ischemia may be required for pro found oxygen radical damage. Another explanation for the lack of evidence of oxygen radical damage in whole tissue addressed by Lundgren et aL (1991) is that damage may be localized to a small compart ment such as the endothelium. Hyperglycemic isch emia can cause endothelial swelling (Paljarvi et aI., 1983) , and transferrin is highly localized in and near the endothelium. Furthermore, ischemia/reper fusion stimulates arachidonic acid metabolism and increases superoxide anion in the vicinity of the vasculature (Kontos et aI., 1992; Nelson et aI., 1992) . Superoxide, in turn, can attack ferritin (Bie mond et aI., 1984), mobilize iron, and thereby aug ment vascular oxygen radical damage. The fact that tirilazad is extremely lipophilic and is retained in endothelial membranes in cell culture (Audus et aI., 1991) is consistent with the possibility that much of the initiating oxygen radical injury occurs at the level of the vasculature or possibly astrocytes sur rounding the vasculature. If this is the case, tiri lazad may be acting by improving the homogeneity of microcirculatory reflow or by stabilizing the blood-brain barrier and associated transport sys tems.
Others have described histological changes and cell swelling during early reperfusion after 30 min of hyperglycemic ischemia (Kalimo et aI., 1981; Pal jarvi, 1984) . We did not perform histology in the present study, but cell swelling would be prominent in the vehicle group where ATP was completely lost in most of the dogs. In the tirilazad-treated group, most of the dogs had near normal levels of ATP at 180 min of reperfusion (Fig. 5) , indicating that most of the cells were still viable. However, we cannot exclude that significant ultrastructural changes were underway that would lead to eventual necro sis. Therefore, the results of the present study should not be taken as evidence that tirilazad pro vides neuroprotection from hyperglycemic isch emia, but only that it is capable of preserving via bility during the early critical moments of reperfu sion. Nevertheless, these results support the concept that a mechanism involving lipid peroxida tion can become the rate-limiting mechanism for metabolic recovery when acidosis becomes ex treme under conditions of prolonged hyperglycemic ischemia.
